Our study thus indicates that the ZNF217-ΔE4 isoform triggers, directly or indirectly, a poor phenotype in breast cancer cells that may involve dysregulated ZNF217-WT expression levels. This evidence concerns the gene ZNF217 and breast carcinoma.